Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VU0152100 是一种选择性 M4 mAChR 变构增强剂,EC50为 380 ± 93 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 249 | 现货 | ||
2 mg | ¥ 353 | 现货 | ||
5 mg | ¥ 575 | 现货 | ||
10 mg | ¥ 927 | 现货 | ||
25 mg | ¥ 1,760 | 现货 | ||
50 mg | ¥ 3,350 | 现货 | ||
100 mg | ¥ 5,850 | 现货 | ||
200 mg | ¥ 7,750 | 现货 | ||
500 mg | ¥ 9,800 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 779 | 现货 |
产品描述 | VU0152100 is an effective and selective allosteric potentiator of M4 mAChR (EC50: 380 ± 93 nM). |
体外活性 | VU0152100 was selective for M4 relative to M1, M2, M3, and M5. VU0152100 dose-dependently potentiated the response to an EC20 concentration of ACh (EC50: 1.9 ± 0.2 μM) and increased the maximal response to ACh to approximately 130%. VU0152100 (10 μM) also increased the potency of ACh to induce GIRK-mediated thallium flux, as manifest by a robust (≈30-fold) leftward shift in the ACh CRC from 77 ± 1.2 nM (veh) to 2.35 ± 0.5 nM [1]. |
体内活性 | Systemic administration of VU0152099 and VU0152100 provides robust brain levels of these compounds, the effects of VU0152099 and VU0152100 were evaluated in reversing amphetamine-induced hyperlocomotion in rats using a dose of 56.6 mg/kg i.p. for each compound with a 30-min pretreatment interval [1]. |
别名 | VU152100 |
分子量 | 341.43 |
分子式 | C18H19N3O2S |
CAS No. | 409351-28-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (131.80 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.9289 mL | 14.6443 mL | 29.2886 mL | 73.2215 mL |
5 mM | 0.5858 mL | 2.9289 mL | 5.8577 mL | 14.6443 mL | |
10 mM | 0.2929 mL | 1.4644 mL | 2.9289 mL | 7.3221 mL | |
20 mM | 0.1464 mL | 0.7322 mL | 1.4644 mL | 3.6611 mL | |
50 mM | 0.0586 mL | 0.2929 mL | 0.5858 mL | 1.4644 mL | |
100 mM | 0.0293 mL | 0.1464 mL | 0.2929 mL | 0.7322 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
VU0152100 409351-28-6 Neuroscience AChR VU 152100 VU 0152100 Inhibitor VU152100 Muscarinic acetylcholine receptor inhibit mAChR VU-152100 VU-0152100 inhibitor